» Articles » PMID: 17367492

Incidence and Mortality of Venous Thrombosis: a Population-based Study

Overview
Publisher Elsevier
Specialty Hematology
Date 2007 Mar 21
PMID 17367492
Citations 433
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Estimates of the incidence of venous thrombosis (VT) vary, and data on mortality are limited.

Objectives: We estimated the incidence and mortality of a first VT event in a general population.

Methods: From the residents of Nord-Trøndelag county in Norway aged 20 years and older (n = 94 194), we identified all cases with an objectively verified diagnosis of VT that occurred between 1995 and 2001. Patients and diagnosis characteristics were retrieved from medical records.

Results: Seven hundred and forty patients were identified with a first diagnosis of VT during 516,405 person-years of follow-up. The incidence rate for all first VT events was 1.43 per 1000 person-years [95% confidence interval (CI): 1.33-1.54], that for deep-vein thrombosis (DVT) was 0.93 per 1000 person-years (95% CI: 0.85-1.02), and that for pulmonary embolism (PE) was 0.50 per 1000 person-years (95% CI: 0.44-0.56). The incidence rates increased exponentially with age, and were slightly higher in women than in men. The 30-day case-fatality rate was higher in patients with PE than in those with DVT [9.7% vs. 4.6%, risk ratio 2.1 (95% CI: 1.2-3.7)]; it was also higher in patients with cancer than in patients without cancer [19.1% vs. 3.6%, risk ratio 3.8 (95% CI 1.6-9.2)]. The risk of dying was highest in the first months subsequent to the VT, after which it gradually approached the mortality rate in the general population.

Conclusions: This study provides estimates of incidence and mortality of a first VT event in the general population.

Citing Articles

Age- and sex-dependency of thrombin generation parameters in the general Italian population: the Moli-sani study.

Costanzo S, de Laat B, Di Castelnuovo A, van der Vorm L, De Curtis A, Cerletti C Front Cardiovasc Med. 2025; 12:1528871.

PMID: 40060967 PMC: 11885247. DOI: 10.3389/fcvm.2025.1528871.


The role of controlling nutritional status score in predicting postthrombotic syndrome in patients with lower extremity deep venous thrombosis.

Lin S, Zhu N, Zhang S Thromb J. 2025; 23(1):19.

PMID: 40055800 PMC: 11887394. DOI: 10.1186/s12959-025-00701-3.


Angioplasty or stenting for deep venous thrombosis.

Flumignan R, Nakano L, Flumignan C, Baptista-Silva J Cochrane Database Syst Rev. 2025; 2:CD011468.

PMID: 39968829 PMC: 11837241. DOI: 10.1002/14651858.CD011468.pub2.


Role of von Willebrand factor, platelets, and aberrant flow in the initiation of venous thrombosis.

Mereweather L, Harwood D, Ahnstrom J, van Batenburg-Sherwood J, Salles-Crawley I, Crawley J Sci Adv. 2025; 11(6):eadr5250.

PMID: 39908367 PMC: 11797557. DOI: 10.1126/sciadv.adr5250.


External validation of a novel cancer-associated venous thromboembolism risk assessment score in a safety-net hospital.

Dulberger K, La J, Li A, Lotfollahzadeh S, Jose A, Do N Res Pract Thromb Haemost. 2025; 9(1):102650.

PMID: 39839661 PMC: 11745955. DOI: 10.1016/j.rpth.2024.102650.